Allogenic Thymocyte-Depleted Thymus Tissue-Agdc Interactions

Brand names: Rethymic

Route: Intramuscular

Contraindications

4 CONTRAINDICATIONS None. None.

Pregnancy & Breastfeeding

8.1 Pregnancy Risk Summary There are no clinical data with RETHYMIC in pregnant women. No animal reproductive and developmental toxicity studies have been conducted with RETHYMIC. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively.

1 interaction on record